142 completed, 38 unknown, 17 terminated, 12 recruiting. 231 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 231 | Completed 142, Unknown 38, Terminated 17, Recruiting 12, Not yet recruiting 10, Withdrawn 7, Active not recruiting 3, Enrolling by invitation 2 |
Follow Diabetes Complications: new trials by email Literature Review of Diabetes Complications trials Research Report on Diabetes Complications
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Naoxintong Capsule, Placebo - Diabetic Nephropathy | Phase 4 | Not yet recruiting | Chen Xiangmei | 410 | 2027-03-01 | 2026-07-13 |
| Efficacy of Topical Lidocaine Gel vs. Oral Duloxetine for Painful Diabetic Peripheral Neuropathy Topical Lidocaine 2% Gel, Duloxetine (60 MG) - Painful Diabetic Neuropathy (PDN), Diabetic Neuropathies | Phase 4 | Not yet recruiting | Wah Medical college , POF hospital | 80 | 2026-12-01 | 2026-09-02 |
| Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy Cognitive Behavioral Therapy (CBT), Oral Medication, Topical Medication - Painful Diabetic Neuropathy (PDN), Diabetic Nephropathies | Phase 4 | Not yet recruiting | University of Michigan | 600 | 2026-11-01 | 2026-10-21 |
| Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia Lower-Extremity Revascularization, Donaperminogene Seltoplasmid - Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer | Phase 4 | Not yet recruiting | First Affiliated Hospital of Wenzhou Medical University | 180 | 2026-10-20 | 2026-09-18 |
| Iopidine to Decrease Intraocular Pressure Rise After Injections Apraclonidine 1.0% ophthalmic solution - Macular Degeneration, Diabetic Retinopathy | Phase 4 | Not yet recruiting | Retina Consultants of Delmarva | 120 | 2026-10-01 | 2026-10-23 |
| Role of Finerenone in African American Veterans With Diabetic Kidney Disease Finerenone 10 MG, Empagliflozin 10 MG - Diabetic Kidney Disease | Phase 4 | Not yet recruiting | Washington D.C. Veterans Affairs Medical Center | 30 | 2026-10-01 | 2026-08-21 |
| Randomized, Controlled Study to Investigate the 12-month Efficacy and Safety of Resveratrol Vitamin Supplements in Patients With Non-proliferative Diabetic Retinopathy Without Center Involved Diabetic Macular Edema (REVOLUTION Study) Resveratrol-Containing Vitamin Supplement - Diabetic Retinopathy, Non Proliferative Diabetic Retinopathy | Phase 4 | Completed | University of Athens | 100 | 2026-09-30 | 2026-10-09 |
| Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP. PDS Implant filled with 100 mg/mL Ranibizumab, Ranibizumab - Proliferative Diabetic Retinopathy, Diabetic Retinopathy | Phase 4 | Not yet recruiting | Southeast Retina Center, Georgia | 20 | 2026-09-01 | 2026-10-13 |
| Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard Anesthesia Iheezo, Lidocaine pledget - Macular Degeneration, Diabetic Retinopathy | Phase 4 | Completed | Retina Consultants of Delmarva | 50 | 2026-05-20 | 2026-08-21 |
| Corticosteroid for Diabetic Macular Edema (DME) Study Intravitreal dexamethasone implant - Diabetic Macular Edema (DME), Diabetic Retinopathy | Phase 4 | Recruiting | Vanderbilt University Medical Center | 20 | 2026-04-07 | 2026-09-28 |
| Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study Finerenone, Spironolactone (drug) - Heart Failure, Diabetic Kidney Disease | Phase 4 | Not yet recruiting | Hospital de Messejana Dr. Carlos Alberto Studart Gomes | 60 | 2026-04-01 | 2026-05-13 |
| Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections Chloroprocaine Ophthalmic Gel 3% (IHEEZO), Sham Subconjunctival Injection, Proparacaine Hydrochloride Ophthalmic Solution 0.5% - Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD) | Phase 4 | Enrolling by invitation | Harrow Inc | 236 | 2026-03-31 | 2026-04-07 |
| To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy N Acetyl cysteine, 1200mg (high dose) - Diabetic Retinopathy (DR) | Phase 4 | Recruiting | Ain Shams University | 76 | 2026-01-10 | 2026-06-09 |
| Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery Aflibercept (Eylea) - Diabetic Retinopathy (DR), Diabetic Macular Edema (DME) | Phase 4 | Not yet recruiting | Ahmad Zeeshan Jamil | 166 | 2026-01-01 | 2025-12-24 |
| A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL DermaBind TL - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU) | Phase 4 | Completed | HealthTech Wound Care | 150 | 2025-12-10 | 2026-10-30 |
| ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases ACE Reno - Hypertensive Nephropathy, Auto Immune Disorders | Phase 4 | Recruiting | Ace Cells Lab Limited | 300 | 2025-09-20 | 2025-09-23 |
| A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers XWRAP - Diabetic Foot, Foot Ulcer | Phase 4 | Recruiting | Applied Biologics, LLC | 60 | 2025-08-26 | 2026-02-11 |
| Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers. Amnio-Maxx® Dual Layer Amnion Patch, Standard of Care (Investigator Choice) - Diabetic Foot Ulcer (DFU), Amnio-Maxx | Phase 4 | Recruiting | Royal Biologics | 248 | 2025-08-14 | 2025-10-07 |
| Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic Foot Intraosseous Vancomycin, Intravenous Vancomycin - Diabetic Foot Disease, Diabetic Foot Infection | Phase 4 | Completed | Başakşehir Çam & Sakura City Hospital | 40 | 2025-08-06 | 2026-07-10 |
| Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Standard of Care DFU, Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU - Diabetic Foot, DFU | Phase 4 | Recruiting | BioLab Holdings | 650 | 2025-07-15 | 2025-07-28 |
Showing 20 of 231. Sign in to see all of them.
Diabetic Nephropathies (65) · Diabetic Foot (55) · Diabetic Retinopathy (52) · Diabetic Neuropathies (43) · Diabetes Mellitus (38) · Diabetes Mellitus, Type 2 (37) · Diabetes Mellitus, Type 1 (13) · Albuminuria (9) · Renal Insufficiency, Chronic (9) · Hypertension (8) · Diabetic Ketoacidosis (7) · Macular Edema (7) · Varicose Ulcer (7) · Foot Ulcer (6)
Endocrine System Diseases (231) · Diabetes Mellitus (193) · Cardiovascular Diseases (121) · Vascular Diseases (118) · Diabetic Angiopathies (107) · Metabolic Diseases (80) · Nutritional and Metabolic Diseases (80) · Glucose Metabolism Disorders (73) · Female Urogenital Diseases and Pregnancy Complications (71) · Urogenital Diseases (71) · Female Urogenital Diseases (70) · Male Urogenital Diseases (70) · Urologic Diseases (70) · Kidney Diseases (64)
Ranibizumab (10) · Duloxetine Hydrochloride (8) · Standard of Care (8) · aflibercept (8) · Gabapentin (7) · Bevacizumab (6) · Calcium Dobesilate (6) · Collagenases (6) · Pregabalin (6) · Valsartan (6) · empagliflozin (6) · Insulin Glargine (5) · Losartan (5) · Sodium Chloride (5) · dapagliflozin (5)
Healthpoint (8) · Amsterdam UMC, location VUmc (5) · Boehringer Ingelheim (4) · Novartis Pharmaceuticals (4) · Osiris Therapeutics (4) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (4) · Steno Diabetes Center Copenhagen (4) · University of Aarhus (4) · Assistance Publique - Hôpitaux de Paris (3) · Cairo University (3) · Eli Lilly and Company (3) · Novartis (3) · Peter Rossing (3) · Smith & Nephew, Inc. (3) · University Medical Center Groningen (3)
United States (80) · China (19) · Denmark (15) · Netherlands (12) · Brazil (10) · Egypt (9) · South Korea (9) · Germany (8) · Italy (8) · United Kingdom (8) · Canada (7) · France (7) · Australia (5) · Mexico (5) · Switzerland (4)
Herbert B Slade, MD (6) · Ahmed A Abdel-Kader, MD, PhD (2) · Ahmed A Mohalhal, MD, PhD (2) · Ayman G Elnahry, MD, PhD (2) · Francisco Garcia-Rio, MD (2) · Peter Rossing, MD (2) · Aaron I Vinik, MD, PhD (1) · Ahlem Trifi (1) · Alejandro E Macias, MD (1) · Alireza Esteghamati, MD (1)
PMID 38682786, PMID 35224730, PMID 27611736, PMID 30084288, PMID 30206821, PMID 30243803, PMID 30521533, PMID 31139483, PMID 31802967, PMID 32411431, PMID 32427087, PMID 38449081, PMID 38770818, PMID 39963952, PMID 41665872, PMID 11128341, PMID 11351356, PMID 11463434, PMID 12893742, PMID 16123474, PMID 16163360, PMID 16291063, PMID 16291066, PMID 16316360, PMID 17425550, PMID 17977931, PMID 18496508, PMID 18784623, PMID 18796160, PMID 19366972, PMID 19526210, PMID 19577022, PMID 19637208, PMID 20393508, PMID 20413516, PMID 20416952, PMID 20465525, PMID 20668482, PMID 20966122, PMID 21146749, PMID 21346609, PMID 21372298, PMID 21622669, PMID 21719618, PMID 21775755, PMID 21898720, PMID 22080911, PMID 22169682, PMID 22176513, PMID 22250209
2014 (2), 2015 (2), R01NS057594 (2), 2005 (1), 2008 (1), 2009 (1), 2019 (1), 2023 (1)